Health Products

APO-AMITRIPTYLINE 10mg (2021-04-13)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

APO-AMITRIPTYLINE 10mg

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
RF0410
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
APO-AMITRIPTYLINEDIN 02403137TabletAMITRIPTYLINE HYDROCHLORIDE 10mg

Reason

Presence of higher than accepted levels of a nitrosamine impurity known as N-nitrosodimethylamine (NDMA) in the affected lot.

Depth of distribution

Retailers, Wholesalers, Healthcare Establishments
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime